SMN2 and proximal spinal muscular atrophy: Although there are several available transgenic mouse models of SMA, inter-species differences between mice and humans, such as the existence of SMN2 in humans, hamper the translation of the findings in mouse studies to human clinical trials (Harahap et al., 2012; Martínez-Hernández et al., 2009; Park et al., 2010).